IQVIA jumps on quarterly results beat

IQVIA Holdings

22/07/2025 15:22

Updates

** Shares of contract research firm IQVIA Holdings IQV.N rise 17.4% to a near four-month high of $186.35

** Stock is set for its best day ever, if gains hold

** Co reports Q2 adj. profit of $2.81/share vs analysts' average estimate of $2.77/share - LSEG

** IQV's quarterly revenue of $4.02 billion beats analysts' average expectation of $3.96 billion

** Q2 sales at co's technology and analytics unit was $1.63 billion, vs estimates of $1.60 billion

 ** Co forecasts annual adj. profit between $11.75 per share  and $12.05 per share, compared with analysts' average estimate of $11.84/share

** "The overall market environment remains essentially unsettled and there is still uncertainty persisting regarding future administration policies affecting the biopharmaceutical industry," says CEO Ari Bousbib in an investor call

** Brokerage Evercore ISI says, "IQV's results point to a potential inflection in its biopharma demand environment, which would bode well as we enter 2026"

** Including session moves, stock down 6.2% YTD

 (Reporting by Christy Santhosh and Siddhi Mahatole)

 ((Christy.Santhosh@thomsonreuters.com))